In Situ Hybridization, with or Without Tyramide Signal Amplification, in Evaluation of Human Papillomavirus Status Inearly Stage Cervical Carcinoma

In Situ Hybridization, with or Without Tyramide Signal Amplification, in Evaluation of Human Papillomavirus Status Inearly Stage Cervical Carcinoma

Bibliographic Details
Main Authors:	Kubelka-Sabit K, Prodanova I, Zografski G, Basheska N
Format:	Article
Language:	English
Published:	Sciendo 2008-01-01
Series:	Balkan Journal of Medical Genetics
Subjects:	cervical carcinoma human papillomavirus (hpv) in situ hybridization (ish) tyramide signal amplification (tsa)
Online Access:	https://doi.org/10.2478/v10034-008-0016-y

Similar Items

Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies
by: Edwin Roger Parra, et al.
Published: (2020-01-01)

Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma
by: Zhao Zhang, et al.
Published: (2019-04-01)

Use of fluorescent oligonucleotide probes for differentiation between Paracoccidioides brasiliensis and Paracoccidioides lutzii in yeast and mycelial phase
by: Thales Domingos Arantes, et al.

Specificity Re-evaluation of Oligonucleotide Probes for the Detection of Marine Picoplankton by Tyramide Signal Amplification-Fluorescent In Situ Hybridization
by: Virginie Riou, et al.
Published: (2017-05-01)

Involvement of Human Papillomaviruses in Cervical Cancer
by: Xuelian Wang, et al.
Published: (2018-11-01)

Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review
by: Biyuan Xing, et al.
Published: (2021-02-01)

Cervical Cancer and Human Papillomavirus Awareness among Women in Saudi Arabia
by: Khalid Akkour, et al.
Published: (2021-12-01)

Secondary school girls' knowledge and practice on human papillomavirus (HPV), cervical cancer and human papillomavirus (HPV) vaccination in Kuantan, Pahang, Malaysia
by: Khin Thandar Aung, et al.
Published: (2017-01-01)

Droplet-free digital immunoassay based on electrochemiluminescence
by: Kentaro Ito, et al.
Published: (2023-05-01)

Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study
by: Federico Zito Marino, et al.
Published: (2021-03-01)

Whole-Genome Analysis of Human Papillomavirus Type 16 Prevalent in Japanese Women with or without Cervical Lesions
by: Yusuke Hirose, et al.
Published: (2019-04-01)

Development of a highly sensitive immunohistochemical method to detect neurochemical molecules in formalin-fixed and paraffin-embedded tissues from autopsied human brains
by: Satoshi eGoto, et al.
Published: (2015-03-01)

Evaluation of human papillomavirus genotype distribution in cervical samples
by: Ayfer Bakir, et al.
Published: (2021-01-01)

Comparative effects of two in situ hybridization methods for the pinewood nematode (Bursaphelenchus xylophilus)
by: Chunyu Wang, et al.
Published: (2023-11-01)

Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer
by: Rossana de Araújo Catão Zampronha, et al.
Published: (2013-06-01)

Characterization and Diversity of 243 Complete Human Papillomavirus Genomes in Cervical Swabs Using Next Generation Sequencing
by: Ardashel Latsuzbaia, et al.
Published: (2020-12-01)

Cervical Cancer, Papillomavirus, and miRNA Dysfunction
by: Evelyn Gabriela Bañuelos-Villegas, et al.
Published: (2021-12-01)

Distribution of human papillomavirus genotypes in suspected women cytological specimens from Tehran, Iran
by: Alireza Tabibzadeh, et al.
Published: (2022-02-01)

Molecular Epidemiology of Human Papillomavirus
by: Talia Hoory, et al.
Published: (2008-03-01)

Point‐of‐care multiplexed single‐cell protein secretion analysis based on tyramide signal amplification
by: Fengjiao Zhu, et al.
Published: (2023-02-01)

Prevalence of High risk Human Papillomavirus in cervical dysplasia and cancer samples from twin cities in Pakistan
by: Sana Gul, et al.
Published: (2015-05-01)

Persistent human papillomavirus infection in the etiology of cervical carcinoma: The role of immunological, genetic, viral and cellular factors
by: Živadinović Radomir, et al.
Published: (2014-01-01)

Acceptability of deferring the start of cervical cancer screening to age 30 for women vaccinated against human papillomavirus
by: Gessica Martello, et al.
Published: (2023-12-01)

Prevalence and genotypic distribution of high-risk human papillomavirus infection among women screened for cervical cancer at Lampang Cancer Hospital
by: Duriya Fongmoon, et al.
Published: (2015-09-01)

Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil
by: Geni NL Camara, et al.
Published: (2003-10-01)

Global Variation of Human Papillomavirus Genotypes and Selected Genes Involved in Cervical Malignancies
by: R.S. Akram Husain, et al.
Published: (2016-03-01)

Comparison of Classical and Secondary Cytologic Criteria Relative to Hybrid Capture for Diagnosing Cervical-vaginal Infection by Human Papillomavirus
by: Renata Margarida Etchebehere, et al.
Published: (2016-01-01)

Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
by: Laura Reques, et al.
Published: (2021-05-01)

Knowledge of cervical cancer, human papillomavirus (HPV), and acceptance of the HPV vaccine among parents of daughters in Riyadh, Saudi Arabia
by: Fatemah A. Alherz, et al.
Published: (2024-05-01)

TSA-PACT: a method for tissue clearing and immunofluorescence staining on zebrafish brain with improved sensitivity, specificity and stability
by: Kang Wang, et al.
Published: (2023-05-01)

Human papillomavirus-associated cervical intraepithelial neoplasia in the presence of iodine deficiency
by: I. V. Sahautdinova, et al.
Published: (2021-10-01)

Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study
by: Dianne Egli-Gany, et al.
Published: (2019-01-01)

Disturbances of Vaginal Microbiome Composition in Human Papillomavirus Infection and Cervical Carcinogenesis: A Qualitative Systematic Review
by: Ming Wu, et al.
Published: (2022-07-01)

An investigation into human papillomavirus (HPV) vaccination for patients undergoing surgery for high-grade cervical or vulvar dysplasia
by: Glenn P. Boyles, et al.
Published: (2022-06-01)

Research of cervical microbiota alterations with human papillomavirus infection status and women age in Sanmenxia area of China
by: Jintao Hu, et al.
Published: (2022-10-01)

Classification and identification of human papillomavirus based on its prevalence and development of cervical lesion among Iranian women
by: Mitra Moeinzadeh, et al.
Published: (2020-09-01)

Vaccination against human papillomavirus after adjuvant therapy of cervical intraepithelial neoplasia
by: I. I. Kutsenko, et al.
Published: (2022-06-01)

Cervical Cancer and Human Papillomavirus Awareness among Women in Antigua and Barbuda
by: Prasanna Honnavar, et al.
Published: (2023-06-01)

Kosovo women’s knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer
by: Pranvera Zejnullahu Raçi, et al.
Published: (2021-10-01)

Recent Developments in Human Papillomavirus (HPV) Vaccinology
by: Anna-Lise Williamson
Published: (2023-06-01)